申请人:Pliant Therapeutics, Inc.
公开号:US11396506B2
公开(公告)日:2022-07-26
The invention relates to compounds of formula (A):
or a salt thereof, wherein R1, R2, R5a, R5b, R6a, R6b, R7a, R7b, R8a, R8b, R9a, R9b, R10a, R10b, R11a, R11b, R21, n, and G are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are αVβ6 integrin inhibitors that are useful for treating fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
本发明涉及式(A)化合物:
或其盐,其中 R1、R2、R5a、R5b、R6a、R6b、R7a、R7b、R8a、R8b、R9a、R9b、R10a、R10b、R11a、R11b、R21、n 和 G 如本文所述。式(I)化合物及其药物组合物是αVβ6整合素抑制剂,可用于治疗纤维化,如特发性肺纤维化(IPF)和非特异性间质性肺炎(NSIP)。